Q3 2025 · 13F-HR
Forefront Analytics, LLCholdings as filed
Filed 2025-11-21 · accession 0001696802-25-000003
$103.8M
Reported value
43
Positions
2025-09-30
Period end
The Brief · Forefront Analytics, LLC · Q3 2025
AI · grounded in 13F
Forefront Analytics, LLC established a new position in ESGD valued at $17.2M. The fund also initiated new stakes in NULV for $10.9M and MTUM for $9.6M. Additional new positions include ESGE at $8.6M and VWO at $7.4M. Total assets under management stand at $103.8M across 43 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46435G516 | ESGD | ISHARES TR | $17.2M | 16.6% | 185,230 | Common | SOLE |
| 67092P300 | NULV | NUSHARES ETF TR | $10.9M | 10.5% | 247,947 | Common | SOLE |
| 46432F396 | MTUM | ISHARES TR | $9.6M | 9.26% | 37,494 | Common | SOLE |
| 46434G863 | ESGE | ISHARES INC | $8.6M | 8.28% | 197,985 | Common | SOLE |
| 922042858 | VWO | VANGUARD INTL EQUITY INDEX F | $7.4M | 7.14% | 136,722 | Common | SOLE |
| 921943858 | VEA | VANGUARD TAX-MANAGED FDS | $6.6M | 6.38% | 110,468 | Common | SOLE |
| 233051200 | DBEF | DBX ETF TR | $5.6M | 5.35% | 119,658 | Common | SOLE |
| 46429B663 | HDV | ISHARES TR | $4.9M | 4.70% | 39,889 | Common | SOLE |
| 33939L688 | ESGG | FLEXSHARES TR | $4.8M | 4.63% | 24,370 | Common | SOLE |
| 46429B697 | USMV | ISHARES TR | $4.3M | 4.14% | 45,153 | Common | SOLE |
| 922908744 | VTV | VANGUARD INDEX FDS | $3.1M | 2.95% | 16,444 | Common | SOLE |
| 464287200 | IVV | ISHARES TR | $2.7M | 2.61% | 4,046 | Common | SOLE |
| 67066G104 | NVDA | NVIDIA CORPORATION | $2.6M | 2.51% | 13,975 | Common | SOLE |
| 922908751 | VB | VANGUARD INDEX FDS | $2.4M | 2.34% | 9,534 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $1.8M | 1.77% | 2,752 | Common | SOLE |
| 46434G509 | HEEM | ISHARES INC | $1.6M | 1.57% | 48,455 | Common | SOLE |
| 46625H100 | JPM | JPMORGAN CHASE & CO. | $1.1M | 1.01% | 3,337 | Common | SOLE |
| 97717W562 | EES | WISDOMTREE TR | $1.0M | 0.96% | 17,919 | Common | SOLE |
| 33738D101 | EMLP | FIRST TR EXCHANGE-TRADED FD | $726,000 | 0.70% | 18,954 | Common | SOLE |
| 921910709 | EDV | VANGUARD WORLD FD | $651,000 | 0.63% | 9,504 | Common | SOLE |
| 464288661 | IEI | ISHARES TR | $586,000 | 0.56% | 4,904 | Common | SOLE |
| 244199105 | DE | DEERE & CO | $516,000 | 0.50% | 1,129 | Common | SOLE |
| 74347R107 | SSO | PROSHARES TR | $455,900 | 0.44% | 4,066 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $403,475 | 0.39% | 3,012 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $394,733 | 0.38% | 4,145 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $390,025 | 0.38% | 1,130 | Common | SOLE |
| 74347R842 | UWM | PROSHARES TR | $368,320 | 0.35% | 7,945 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $349,343 | 0.34% | 4,492 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $320,496 | 0.31% | 12,578 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $317,529 | 0.31% | 3,744 | Common | SOLE |
| 464288513 | HYG | ISHARES TR | $262,000 | 0.25% | 3,229 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $260,281 | 0.25% | 1,313 | Common | SOLE |
| 464287176 | TIP | ISHARES TR | $246,000 | 0.24% | 2,211 | Common | SOLE |
| 464288372 | IGF | ISHARES TR | $239,000 | 0.23% | 3,905 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $231,831 | 0.22% | 412 | Common | SOLE |
| 718172109 | PM | PHILIP MORRIS INTL INC | $231,000 | 0.22% | 1,424 | Common | SOLE |
| 464287242 | LQD | ISHARES TR | $222,000 | 0.21% | 1,991 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $93,173 | 0.09% | 21,518 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $82,432 | 0.08% | 27,027 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $81,666 | 0.08% | 39,452 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $71,593 | 0.07% | 52,258 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $68,351 | 0.07% | 33,180 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $57,768 | 0.06% | 18,109 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.